The U.S. Drug Enforcement Administration considers so-called “hemp-derived” “novel cannabinoids” that do not exist in the hemp plant naturally – such as THC acetate ester, commonly referred to on the market as THC-O – to be illegal.
Rep. Nancy Mace, of South Carolina, is on U.S. House Speaker Kevin McCarthy’s good side.
On the surface, the Republican congresswoman’s loyalty should be good news for marijuana legalization’s prospects on Capitol Hill.
A much-hyped letter from California cannabis regulators to the state’s attorney general raises an intriguing question: Is the Golden State teeing up interstate trade in marijuana?
A Republican U.S. representative from Florida reintroduced legislation that would reclassify marijuana under federal law.
Here are the top 10 marijuana industry trends to watch for in 2023, as determined by MJBizDaily staffers.
On the heels of failed cannabis banking reform, a bipartisan group of 24 federal lawmakers asked President Joe Biden on Thursday to “recognize the merits of full descheduling” of marijuana.
A little more than a month after President Joe Biden signed a new marijuana research bill into law, officials said they intend to open a cannabis-centric research laboratory and think tank in Chicago sometime in 2023.
A challenge to Oregon’s ban on shipping legal marijuana out of state could win in court and set up legal interstate trade.
President Joe Biden made history on Friday when he became the first American president to sign marijuana-specific reform legislation into law.
The months ahead could be shaping up to be the most wonderful time of the year for the U.S. marijuana industry, although insiders warn legislative movement isn’t a sure bet.
After a half-century in which marijuana endured the strictest prohibition allowed under the law, President Joe Biden has set in motion a process that could lead to revolutionary changes for federal MJ policy.
President Joe Biden on Thursday called on the U.S. attorney general and the secretary of the Department of Health and Human Services to begin the process of reviewing marijuana scheduling under federal law – a move that could dramatically reshape how the U.S. government treats MJ and the flourishing industry that has commercialized the plant.
